Bellevue hires partner for drug development venture capital fund
Pureos Bioventures, a Bellevue Asset Management venture capital fund, has appointed Anja Harmeier as a partner. Harmeier was an investment director at the Roche Venture fund over the last four years, sourcing, leading and managing investments including Black Diamond, Vivet, Entrada and NMD. Previously, she ran her own biotech company…
Continue Reading
Subscribe to unlock the full article and access premium financial content.
Click here to read the full story: Citywire

